Poorly differentiated tumours of the foregut (pulmonary, thymic) and small-cell colorectal tumours have a high proliferation capacity (Ki67 antibody > 15%), and may respond to cisplatin/paraplatin plus etoposide 3,23. Here, MKI67 is linked to neoplasm.